For example, compounds with ability to inhibit acetylcholinesterase (AChE) are promising molecules to develop new drug leads for neurodegenerative diseases treatment, such as Alzheimer’s and Parkinson’s diseases, as these pathologies are characterized by a decrease in acetylcholine release [9,18,19]. Here, ACHE is linked to neurodegenerative disease.